Literature DB >> 28963948

Antioxidant potential of Xylopia aethiopica fruit acetone fraction in a type 2 diabetes model of rats.

Aminu Mohammed1, Md Shahidul Islam2.   

Abstract

The fruit decoction of Xylopia aethiopica (Dunal) A. Rich. is widely used for the treatment of diseases associated with oxidative stress such as diabetes, particularly in Africa. The present study was aimed to investigate the effects of X. aethiopica fruit acetone (XAFA) fraction in ameliorating oxidative stress in a type 2 diabetes (T2D) model of rats. The crude X. aethiopica fruit ethanolic extract was fractionated using solvents with increasing polarity and acetone fraction showed significantly (p<0.05) higher in vitro antioxidant potentials which were measured by (1,1-diphenyl-2-picrylhydrazyl radical (DPPH), hydroxyl radical (HRS) and nitric oxide (NO) assays compared to other fractions. It was then subjected to in vivo antioxidant study in a T2D rat model. Acetone fraction depicted potent in vitro antioxidant actions (IC50: DPPH: 19.82±0.73μg/mL; HRS: 25.34±6.19μg/mL; NO: 14.45±2.44μg/mL) compared to other fractions. Additionally, a significant (p<0.05) and dose-dependent improvement on the in vivo antioxidant status was observed in the animals in diabetic treated groups (DXAL, DXAH) compared to the diabetic control (DBC) group. The results of our study suggest that XAFA possesses potent antioxidant potential and could be used to ameliorate oxidative stress associated metabolic complications such as T2D.
Copyright © 2017 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Acetone fraction; Antioxidant; Ethanolic extract; Type 2 diabetes; Xylopia aethiopica

Mesh:

Substances:

Year:  2017        PMID: 28963948     DOI: 10.1016/j.biopha.2017.09.116

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  2 in total

1.  Vindoline-A Natural Product from Catharanthus Roseus Reduces Hyperlipidemia and Renal Pathophysiology in Experimental Type 2 Diabetes.

Authors:  Oluwafemi Omoniyi Oguntibeju; Yapo Aboua; Mediline Goboza
Journal:  Biomedicines       Date:  2019-08-13

2.  Xyloplains A-F, six new guaiane-type sesquiterpenoid dimers from Xylopia vielana.

Authors:  Yang-Guo Xie; Weiyue Zhang; Sheng-Lan Zhu; Tao-Fang Cheng; Guo-Jing Wu; Ishaq Muhammad; Shi-Kai Yan; Yan Zhang; Hui-Zi Jin; Wei-Dong Zhang
Journal:  RSC Adv       Date:  2018-07-18       Impact factor: 3.361

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.